We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMCM
2401
Cheetah Mobile
CMCM
$88.5M
– –
-611
Closed -$11K
CMTL icon
2402
Comtech Telecommunications
CMTL
$50.9M
– –
-3,941
Closed -$111K
CNNE icon
2403
Cannae Holdings
CNNE
$646M
– –
-6,822
Closed -$198K
COGT icon
2404
Cogent Biosciences
COGT
$7.07B
– –
-193
Closed -$2K
COHU icon
2405
Cohu
COHU
$2.19B
– –
-19,902
Closed -$307K
COLL icon
2406
Collegium Pharmaceutical
COLL
$1.17B
– –
-1,757
Closed -$23K
CPAC
2407
Cementos Pacasmayo
CPAC
$1.01B
– –
-3,161
Closed -$28K
CPRX
2408
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-192
Closed -$1K
CRAI icon
2409
CRA International
CRAI
$1.19B
– –
-314
Closed -$12K
CRBP icon
2410
Corbus Pharmaceuticals
CRBP
$168M
– –
-142
Closed -$29K
CRK icon
2411
Comstock Resources
CRK
$3.73B
– –
-72
Closed –
CRMT icon
2412
America's Car Mart
CRMT
$26.7M
– –
-1,725
Closed -$148K
CRNT icon
2413
Ceragon Networks
CRNT
$197M
– –
-100
Closed –
CRON
2414
Cronos Group
CRON
$1.08B
– –
-146
Closed -$2K
CRSP icon
2415
CRISPR Therapeutics
CRSP
$4.77B
– –
-3,247
Closed -$153K
CSTE icon
2416
Caesarstone
CSTE
$71.6M
– –
-804
Closed -$12K
CSWC icon
2417
Capital Southwest
CSWC
$1.47B
– –
-9,918
Closed -$208K
CTLP
2418
DELISTED
Cantaloupe
CTLP
– –
-2,067
Closed -$15K
CULP icon
2419
Culp Inc
CULP
$44.8M
– –
-823
Closed -$16K
CVEO icon
2420
Civeo
CVEO
$350M
– –
-86
Closed -$2K
CVLG icon
2421
Covenant Logistics
CVLG
$928M
– –
-1,758
Closed -$13K
CVLT icon
2422
Commault Systems
CVLT
$4.82B
– –
-2,191
Closed -$109K
CWH icon
2423
Camping World
CWH
$400M
– –
-4,352
Closed -$54K
CWK icon
2424
Cushman & Wakefield Ltd
CWK
$3.23B
– –
-1,349
Closed -$24K
CYCN icon
2425
Cyclerion Therapeutics
CYCN
$15.2M
– –
-383
Closed -$88K
95 96
97
98 99

Similar funds

OU
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.